Back
Hewlett Packard Enterprise Co. Vs. Arrowhead Pharmaceuticals, Inc. Industry Stock Comparison
Buy
66
HPE
Hewlett Packard Enterprise Co.
Last Price:
$25.26
Seasonality Move:
3.16%
Sell
50
ARWR
Arrowhead Pharmaceuticals, Inc.
Last Price:
$68.84
Seasonality Move:
40.49%
Buy
66
Hewlett Packard Enterprise Co. (HPE)
is a Buy
Is Hewlett Packard Enterprise Co. a Buy, Sell or Hold?
-
The current Hewlett Packard Enterprise Co. [HPE] share price is $24.77. The Score for HPE is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
-
HPE is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Arrowhead Pharmaceuticals, Inc. (ARWR)
is a Sell
Is Arrowhead Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Arrowhead Pharmaceuticals, Inc. [ARWR] share price is $68.83. The Score for ARWR is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
ARWR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
HPE Stock Price Chart
What is Hewlett Packard Enterprise Co.'s stock price today?
-
The Hewlett Packard Enterprise Co. share price today is $24.77Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and HPE is experiencing buying pressure, which is a positive indicator for future bullish movement.
ARWR Stock Price Chart
What is Arrowhead Pharmaceuticals, Inc.'s stock price today?
-
The Arrowhead Pharmaceuticals, Inc. share price today is $68.83Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ARWR is experiencing slight buying pressure.
HPE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.11 | Buy |
| Relative Strength Index (14 RSI): | 67.87 | Buy |
| Chaikin Money Flow: | 29304948 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (21.17 - 23.65) | Buy |
| Bollinger Bands (100): | (21.22 - 24.52) | Buy |
ARWR Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.39 | Buy |
| Relative Strength Index (14 RSI): | 76.07 | Buy |
| Chaikin Money Flow: | 2789125 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (37.57 - 58.79) | Buy |
| Bollinger Bands (100): | (20.11 - 45.67) | Buy |
HPE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 22.86 | Buy |
| 20-day SMA: | 22.11 | Buy |
| 50-day SMA: | 23.35 | Buy |
| 200-day SMA: | 20.1 | Buy |
| 8-day EMA: | 23.13 | Buy |
| 20-day EMA: | 22.66 | Buy |
| 50-day EMA: | 22.86 | Buy |
| 200-day EMA: | 21.4 | Buy |
ARWR Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 61.94 | Buy |
| 20-day SMA: | 50.39 | Buy |
| 50-day SMA: | 42.93 | Buy |
| 200-day SMA: | 24.04 | Buy |
| 8-day EMA: | 62.02 | Buy |
| 20-day EMA: | 53.73 | Buy |
| 50-day EMA: | 44.48 | Buy |
| 200-day EMA: | 29.61 | Buy |
Hewlett Packard Enterprise Co. Earnings Growth & HPE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.17 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.07 per share, and an increase next year of $0.46 per share.
Arrowhead Pharmaceuticals, Inc. Earnings Growth & ARWR Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.49 per share, and a decrease next year of $3.13 per share.
Hewlett Packard Enterprise Co. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Arrowhead Pharmaceuticals, Inc. Technical Analysis
| Nov 25 | Nov 26 | Nov 28 | Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 25 | 26 | 28 | 01 | 02 | 03 | 04 | 05 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||